Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7532084 | 0.98 | KDM4E (0.37) | KDM4EALDH1A1TDP1USP2MEN1 | |
| SCHEMBL7539017 | 0.95 | KDM4E (0.39) | KDM4EALDH1A1TDP1USP2MEN1 | |
| SCHEMBL7533261 | 0.88 | KDM4E (0.41) | KDM4EALDH1A1TDP1USP2MEN1 | |
| SCHEMBL7538190 | 0.86 | KDM4E (0.39) | KDM4EALDH1A1TDP1USP2MEN1 | |
| SCHEMBL7533791 | 0.84 | KDM4E (0.40) | KDM4EALDH1A1MEN1KMT2AHTT | |
| SCHEMBL5873088 | 0.82 | EPHX2 (0.32) | KDM4EALDH1A1MEN1KMT2AEPHX2 | |
| SCHEMBL1975023 | 0.82 | KDM4E (0.46) | KDM4EALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL30996063 | 0.80 | KDM4E (0.44) | KDM4EALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL4445579 | 0.80 | KDM4E (0.44) | KDM4EALDH1A1TDP1MEN1KMT2A | |
| SCHEMBL15779744 | 0.80 | KDM4E (0.36) | KDM4EALDH1A1TDP1USP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6469220-B2 | MONOMERS FOR PHOTORESIST MATERIALS WITH HIGH TRANSPARENCY AND A GREAT AFFINITY FOR THE SUBSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-10-22 | — | — | US | disclosed |
| US-20020087033-A1 | Novel tertiary alcohol compounds having an alicyclic structure | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020087033-A1 | Novel tertiary alcohol compounds having an alicyclic structure | ADH1A, ADH1C, ADH5 | KDM4E 2665/4885ALDH1A1 5/4885TDP1 2326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.